Saudi Oncology Society clinical management guidelines for prostate cancer. - Wikidata - wikimedia - TriplyDB

Saudi Oncology Society clinical management guidelines for prostate cancer.

Saudi Oncology Society clinical management guidelines for prostate cancer.

http://www.wikidata.org/entity/Q34997355

about

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer An early-detection programme for prostate cancer in Saudi men: A call from a tertiary-care centre in the Eastern province.Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for prostate cancer 2017.

P2860

Q26747782-5BF1686D-8825-4DD7-8235-562A403FE7D5 Q38505558-BB42925B-3D3C-4C41-9DA8-AE859C9539BD Q55024078-709644CB-056D-44F4-96D6-4F3B812A8F8E

P2860

Saudi Oncology Society clinical management guidelines for prostate cancer.

http://www.wikidata.org/entity/Q34997355

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Saudi Oncology Society clinical management guidelines for prostate cancer.

@ast

Saudi Oncology Society clinical management guidelines for prostate cancer.

@en

Saudi Oncology Society clinical management guidelines for prostate cancer.

@nl

type

label

Saudi Oncology Society clinical management guidelines for prostate cancer.

@ast

Saudi Oncology Society clinical management guidelines for prostate cancer.

@en

Saudi Oncology Society clinical management guidelines for prostate cancer.

@nl

prefLabel

Saudi Oncology Society clinical management guidelines for prostate cancer.

@ast

Saudi Oncology Society clinical management guidelines for prostate cancer.

@en

Saudi Oncology Society clinical management guidelines for prostate cancer.

@nl

P1433

Q34997355-84E48510-D9D1-4ABB-A773-301A8E4947BB

P1476

Q34997355-8362FE95-0E3A-48DF-AA9E-D391C624C822

P2093

Q34997355-0EBB6E6F-7A3B-411E-9AE3-986066C6FFE6

Q34997355-4578ABE7-EA26-43BE-BE2B-F150E780BBE5

Q34997355-46714FB1-AEB9-48C4-8AC0-1FE8A5678F59

Q34997355-7953132A-1ABF-4223-A24D-EB29DF19403D

Q34997355-832CF833-EF64-483A-A82E-C94F9DAC5BCE

Q34997355-9353C6D0-453C-4601-9424-9349594E1C13

Q34997355-9881549C-A0C8-4803-A9FB-2F3C6A02409E

Q34997355-98F9E351-DF2F-455E-8DB3-C866F60F475D

Q34997355-AE100942-A377-457B-93BC-C92A558A04DA

Q34997355-E419C014-A7C0-49AA-89B3-AD20C7C1EA28

P2860

Q34997355-011F1F3A-2F01-4C35-8AF1-53790F1FBE6A

Q34997355-06B8E2AC-3F6E-4024-BFF8-779338D62316

Q34997355-093DD5BC-2BF2-4429-84F7-A8BCEFE76D21

Q34997355-139DE9B5-F0B4-40DE-96E5-9027701F554A

Q34997355-1499FDCE-2523-4BA6-BB20-3C1E6197F981

Q34997355-14EDA3CC-9A18-4E01-92F9-97F07CEC12B6

Q34997355-177BCCD9-FC34-49DF-B5A3-1170E011459D

Q34997355-186FE132-AD2E-41F0-A859-ED19BFEE5B5D

Q34997355-19EA3F78-B537-4A72-A39E-44265F1CBC94

Q34997355-19ED164E-A0E2-4572-A100-A840EAABCFF0

P304

Q34997355-6ECD46DF-D671-4804-93AD-C061FE82ACB8

P31

Q34997355-AEA5AA8E-3967-4F2E-99C0-538BEA036E18

P356

Q34997355-CEEEBE46-5857-408C-98DE-AAEB902D541A

P478

Q34997355-5E407BE8-F507-4BDE-9A21-F0C2E3F057E3

P50

Q34997355-2664EBF8-3987-475B-986F-FAA62471F49F

P577

Q34997355-BB7240FB-4BBA-4894-88D3-B4FD9368D8C6

P698

Q34997355-E9CF59DA-D7BE-45AC-A554-7362474BB641

P932

Q34997355-A0B74E23-522D-4BAA-AA6A-E77D9B6E49CF

P356

0974-7796.78550

P1433

P1476

Saudi Oncology Society clinical management guidelines for prostate cancer

@en

P2093

Abdullah Al Ghamdi

http://www.w3.org/2001/XMLSchema#string

Ashraf J Abusamra

http://www.w3.org/2001/XMLSchema#string

Danny Rabah

http://www.w3.org/2001/XMLSchema#string

Dany Rabbah

http://www.w3.org/2001/XMLSchema#string

Eyad Al Saeed

http://www.w3.org/2001/XMLSchema#string

Hussain Kushi

http://www.w3.org/2001/XMLSchema#string

Khaled Balaraj

http://www.w3.org/2001/XMLSchema#string

Khalid Al Ghamdi

http://www.w3.org/2001/XMLSchema#string

Mohammed Al Otaibi

http://www.w3.org/2001/XMLSchema#string

Naser Al Bogami

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Maximal androgen blockade for advanced prostate cancer.

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

Salvage prostate cryoablation: initial results from the cryo on-line data registry.

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.

Natural history of progression after PSA elevation following radical prostatectomy.

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

P304

S10-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0974-7796.78550

http://www.w3.org/2001/XMLSchema#string

P478

3 Suppl

http://www.w3.org/2001/XMLSchema#string

P50

Shouki Bazarbashi

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21673847

http://www.w3.org/2001/XMLSchema#string

P932

3099482

http://www.w3.org/2001/XMLSchema#string